170 related articles for article (PubMed ID: 35914728)
1. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.
Shen Z; Ma J; Peng R; Hu B; Zhao Y; Liu S; Hong J
Transplant Cell Ther; 2022 Nov; 28(11):749.e1-749.e7. PubMed ID: 35914728
[TBL] [Abstract][Full Text] [Related]
2. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
Hu B; Qiu Y; Hong J
Ocul Surf; 2020 Apr; 18(2):298-304. PubMed ID: 31954196
[TBL] [Abstract][Full Text] [Related]
3. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
4. Tear Cytokines as Biomarkers for Acute Ocular Graft-Versus-Host Disease.
Qiu Y; Hu B; Peng RM; Huang JF; Hong J
Cornea; 2022 Nov; 41(11):1405-1411. PubMed ID: 35184125
[TBL] [Abstract][Full Text] [Related]
5. Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
Ma J; Shen Z; Peng R; Li C; Hu B; Hong J
Transplant Cell Ther; 2021 Mar; 27(3):232.e1-232.e6. PubMed ID: 33781517
[TBL] [Abstract][Full Text] [Related]
6. Tear Cytokines Associated With Therapeutic Effects in Chronic Ocular Graft-Versus-Host Disease.
Ma J; Shen Z; Peng R; Li C; Zhao Y; Hu B; Hong J
Cornea; 2023 Feb; 42(2):211-216. PubMed ID: 36582034
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD).
Shen Z; Hu B; Tao L; Ma J; Peng R; Zhao Y; Hong J
Front Med (Lausanne); 2023; 10():1277194. PubMed ID: 37964878
[TBL] [Abstract][Full Text] [Related]
8. Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.
Serapicos P; Kim C; Barros SL; Mendes Silva Jordão IMB; Hiyane MI; Barbosa de Sousa L; Zecchin VG; Camara NOS; de Oliveira LA
Ocul Immunol Inflamm; 2023 May; 31(4):701-709. PubMed ID: 35404738
[TBL] [Abstract][Full Text] [Related]
9. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients.
Nair S; Vanathi M; Mahapatra M; Seth T; Kaur J; Velpandian T; Ravi A; Titiyal JS; Tandon R
Ocul Surf; 2018 Jul; 16(3):352-367. PubMed ID: 29723628
[TBL] [Abstract][Full Text] [Related]
10. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
11. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.
Singh RB; Yung A; Coco G; Sinha S; Dohlman TH; Yin J; Dana R
Ocul Surf; 2020 Oct; 18(4):731-735. PubMed ID: 32738300
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.
Ma J; Li C; Zhao Y; Shen Z; Hu B; Peng R; Hong J
BMC Ophthalmol; 2022 Jan; 22(1):18. PubMed ID: 35012541
[TBL] [Abstract][Full Text] [Related]
14. Molecular Biomarkers in Ocular Graft-versus-Host Disease: A Systematic Review.
Bohlen J; Gomez C; Zhou J; Martinez Guasch F; Wandvik C; Sunshine SB
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254702
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Pietraszkiewicz AA; Payne D; Abraham M; Garced A; Devarasetty KC; Wall M; Menezes SM; Ugarte S; Pirsl F; Goklemez S; Ferris FL; Barrett J; Battiwalla M; Childs RW; Pavletic SZ; Bishop RJ
Bone Marrow Transplant; 2021 Aug; 56(8):1850-1858. PubMed ID: 33686249
[TBL] [Abstract][Full Text] [Related]
16. Update on ocular graft-versus-host disease.
Nair S; Vanathi M; Mukhija R; Tandon R; Jain S; Ogawa Y
Indian J Ophthalmol; 2021 May; 69(5):1038-1050. PubMed ID: 33913829
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Corneal Epithelial Changes and Related Factors in Ocular Chronic Graft-Versus-Host Disease (GVHD) by in Vivo Confocal Microscopy.
Liu S; Peng R; Ma J; Shen Z; Hu B; Zhao Y; Hong J
Ocul Immunol Inflamm; 2024 May; 32(4):454-462. PubMed ID: 36758227
[TBL] [Abstract][Full Text] [Related]
18. The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation.
Chen Y; Zhuang X; Wang L; Xu Y; Sun Z; Ren Y; Chen F; Ma X; Tang X; Zhang X
Ocul Immunol Inflamm; 2024 Jan; ():1-8. PubMed ID: 38252122
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.
Singh RB; Yuksel E; Sinha S; Wang S; Taketani Y; Luznik Z; Yin J; Dohlman TH; Dana R
Ocul Surf; 2022 Oct; 26():13-18. PubMed ID: 35843560
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of ocular allergy and dry eye disease.
Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S
Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
